By using AI to analyze more than 400,000 Reddit posts, researchers at Penns School of Engineering and Applied Science have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not be fully captured in clinical trials or regulatory documents
Book your complimentary consultation today and find out how GLP-1 therapy can work for your body and lifestyle.
9 Common Questions." FDA: "FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss," "Label: Foundayo (Orforglipron)." National Association of Insurance Commissioners: "Does Insurance Cover Prescription Weight Loss Injectables?" University of Chicago Medicine: "Research shows GLP-1 receptor agonist drugs are effective but come with complex concerns." Massachusetts General Hospital: "Preserving Lean Body Mass in Patients Taking GLP-1 for Weight Loss." UT Southwestern Medical Center: "Weight-loss medications: The 5 most-asked questions." University of Kansas Health System: "Surprises and Concerns About GLP-1 Medications." Brown University Health: "Compounded Weight Loss Medications: What are They and What are Their Risks?" University of Missouri Health: "Thinking About Microdosing GLP-1
Pretty, feminine and confident
doi: (Of importance) This cross-sectional study provides direct evidence that GLP-1 receptor agonist use may be accompanied by reduced intake of protein and selected micronutrients
If you take insulin or sulfonylureas with GLP-1 therapy, check your blood glucose when experiencing cognitive symptoms, as hypoglycemia can mimic brain fog
